17
3
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2086 | ELN-441958 | ELN 441958 | Bradykinin Receptor |
ELN-441958 is a potent, neutral antagonist of B1 receptor, inhibits the binding of the B1 agonist ligand [3H]DAKD to IMR-90 cells with Ki of 0.26 nM. ELN-441958(ELN 441958) is highly selective for B1 over B2 receptors. | |||
T11178L | ELN318463 racemate | ELN318463 (racemate),ELN 318463 racemate | Gamma-secretase |
ELN318463 racemate (ELN 318463 racemate) is the racemate of ELN318463 which is an amyloid precursor protein (APP) selective γ-secretase inhibitor. | |||
T4659 | ELN484228 | Others | |
ELN484228 is a α-synuclein blocker. α-synuclein is a key protein in Parkinson’s disease. | |||
T11178 | ELN318463 | ELN 318463 | Others |
ELN 318463 shows differential inhibition of presenilin (PS1)- and PS2-comprised γ-secretase with EC50s of 12 nM and 656 nM for PS1 and PS2, respectively. ELN 318463 is 51-fold more selective for PS1.ELN 318463 is an amyl... | |||
T0121 | Azelnidipine | CS 905,UR-12592 | Calcium Channel |
Azelnidipine (UR-12592) is a dihydropyridine used as calcium channel blocker. | |||
T61786 | Selnoflast | RG 6418,RO-7486967 | NOD |
Selnoflast (example 6) is a NLRP3 inhibitor[1]. | |||
T6090 | Belnacasan | VX-765 | Caspase |
Belnacasan (VX-765) is an orally active IL-converting enzyme/caspase-1 inhibitor. | |||
T17222 | Velneperit | S2367 | Neuropeptide Y Receptor |
Velneperit (S2367) is potent and selective neuropeptide Y (NPY) Y5 receptor under evaluating for treatment of obesity. | |||
T78613 | Selnoflast calcium | RO-7486967 calcium | NOD-like Receptor (NLR) |
Selnoflast calcium (example 6), an NLRP3 inhibitor[1], is a chemical compound designed to suppress the activity of the NLRP3 inflammasome. | |||
T78614 | Selnoflast potassium | RO-7486967 potassium | NOD-like Receptor (NLR) |
Selnoflast (potassium) (example 6), is an NLRP3 inhibitor. | |||
T70951 | ELND006 | ||
ELND006 is a novel gamma secretase inhibitor previously under investigation for the oral treatment of Alzheimer's disease. ELND006 shows poor solubility and has moderate to high permeability. The in vivo performance of t... | |||
T68806 | Azelnidipine, (S)- | ||
Azelnidipine, (S)-, is an L-type calcium channel blocker (CCB). Studies have shown that in patients with hypertension (HT) and heart failure preserved ejection fraction (HFpEF), azelnidipine improved the severity of HF a... | |||
T10439 | Azelnidipine D7 | CS-905 D7 | Others |
Azelnidipine D7 is a deuterium-labeled Azelnidipine. Azelnidipine is an L-type calcium channel blocker. | |||
T68807 | Azelnidipine, (R)- | ||
Azelnidipine, (R)-, is an L-type calcium channel blocker (CCB). Studies have shown that in patients with hypertension (HT) and heart failure preserved ejection fraction (HFpEF), azelnidipine improved the severity of HF a... | |||
T70635 | ELND007 | ||
ELND007 is a Gamma secretase inhibitor. | |||
T35045 | Velnacrine | 1,2,3,4-tetrahydro-9-aminoacridin-1-ol maleate,1-hydroxytacrine,9-ATHCO,9-amino-1,2,3,4-tetrahydroacridin-1-ol | Others |
Velnacrine (1,2,3,4-tetrahydro-9-aminoacridin-1-ol maleate) is a biochemical. | |||
TNU1448 | NovelN4-Benzoyl-7’-O-(4,4’-dimethoxytrityl oxy)morpholinocytosine | ||
novelN4-Benzoyl-7'-O-(4,4'-dimethoxytrityl oxy)morpholinocytosine is a Nucleoside Derivative - Morpholino nucleoside. |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-02636 | Elastin Protein, Mouse, Recombinant (His) | Mouse | E. coli |
Major structural protein of tissues such as aorta and nuchal ligament, which must expand rapidly and recover completely. Molecular determinant of the late arterial morphogenesis, stabilizing arterial structure by regulat... | |||
TMPK-00946 | EFEMP1 Protein, Human, Recombinant (His) | Human | HEK293 Cells |
Transversalis fascia EFEMP1, TIMP3 and ELN expressions were decreased, but MMP9 expression was increased in IH patients compared with controls. In IH patients, EFEMP1 was not correlated with TIMP3, but positively correla... | |||
TMPK-01082 | EFEMP1 Protein, Mouse, Recombinant (His) | Mouse | HEK293 Cells |
Transversalis fascia EFEMP1, TIMP3 and ELN expressions were decreased, but MMP9 expression was increased in IH patients compared with controls. In IH patients, EFEMP1 was not correlated with TIMP3, but positively correla... |